Abstract
<h3>Background</h3> Hyperprogressive disease (HPD) is the acceleration of tumor growth observed in patients treated with immunotherapy. HPD was seen to be negatively associated with the overall survival (OS) and progression-free...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
